Group 1: Company Operations - Guizhou Bailin's diabetes hospital in Guiyang is currently in the trial operation phase, with approvals from local health insurance systems [2] - The company has established a strategic partnership with Tencent to promote "Internet + chronic disease medical services" in Guizhou [3] Group 2: Hospital Development - The company is focusing on the establishment of diabetes hospitals in Guiyang and Changsha, with Guiyang being a self-built project and Changsha a collaborative effort [3] - Intentional cooperation with Yunnan Baiyao on the "Tangen Tongluo" project is still in the discussion phase [3] Group 3: Business Strategy - The company plans to accelerate the development of existing products, enhancing market promotion and academic outreach for OTC and prescription drugs [4] - Key products like Yindan Xinnao Tong soft capsules have shown stable growth and have become star products for the company [4] Group 4: Research and Development - The company aims to advance R&D projects, including Tangen Tongluo capsules, leveraging its innovation system and collaborating with research institutions [4] - There is a focus on fostering high-level talent to meet the company's needs for talent reserves and enhance core competitiveness [4]
贵州百灵(002424) - 2015年12月15日投资者关系活动记录表